We are live on ! Find out more
VCM

Voleon Capital Management Portfolio holdings

AUM $5.49B
1-Year Est. Return 56.94%
This Fund
S&P 500
This Quarter Est. Return
+31.2%
1 Year Est. Return
+56.94%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.49B
AUM Growth
+$849M
Cap. Flow
+$57M
Cap. Flow %
1.04%
Top 10 Hldgs %
29.1%
Holding
957
New
177
Increased
251
Reduced
333
Closed
196

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$41.7M
2
META icon
Meta Platforms (Facebook)
META
+$41.2M
3
MRK icon
Merck
MRK
+$26.1M
4
INTU icon
Intuit
INTU
+$24.7M
5
AZN icon
AstraZeneca
AZN
+$23.6M

Top Sells

Rank Stock Value
1
ALAB icon
Astera Labs
ALAB
+$29.3M
2
QCOM icon
Qualcomm
QCOM
+$28.6M
3
FTNT icon
Fortinet
FTNT
+$26.2M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$22.1M
5
LLY icon
Eli Lilly
LLY
+$20.8M

Sector Composition

Rank Sector Weight
1 Technology 34.25%
2 Financials 12.04%
3 Healthcare 11.39%
4 Industrials 10.72%
5 Consumer Discretionary 10.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATO icon
726
Atmos Energy
ATO
$27.6B
$211K ﹤0.01%
+1,224
New +$219K
F icon
727
Ford
F
$55.7B
$209K ﹤0.01%
15,050
-105,849
-88% -$1.43M
EG icon
728
Everest Group
EG
$14.3B
$207K ﹤0.01%
580
-2,860
-83% -$979K
ARGX icon
729
argenx
ARGX
$61.6B
$201K ﹤0.01%
+217
New +$179K
ASX icon
730
ASE Group
ASX
$103B
$201K ﹤0.01%
+4,461
New +$150K
FSLR icon
731
First Solar
FSLR
$22.5B
$201K ﹤0.01%
+852
New +$200K
MBWM icon
732
Mercantile Bank Corp
MBWM
$1.07B
$200K ﹤0.01%
3,485
-3,035
-47% -$160K
VSTS icon
733
Vestis
VSTS
$1.71B
$189K ﹤0.01%
13,011
-15,649
-55% -$175K
TRDA icon
734
Entrada Therapeutics
TRDA
$265M
$186K ﹤0.01%
+25,324
New +$243K
ORN icon
735
Orion Group Holdings
ORN
$379M
$176K ﹤0.01%
+10,459
New +$145K
AQST icon
736
Aquestive Therapeutics
AQST
$600M
$173K ﹤0.01%
+41,561
New +$175K
AVXL icon
737
Anavex Life Sciences
AVXL
$243M
$164K ﹤0.01%
+63,505
New +$188K
GDYN icon
738
Grid Dynamics Holdings
GDYN
$647M
$160K ﹤0.01%
28,185
-9,237
-25% -$57.2K
MNKD icon
739
MannKind Corp
MNKD
$1.21B
$155K ﹤0.01%
36,381
-165,343
-82% -$537K
DLO icon
740
dLocal
DLO
$4.37B
$147K ﹤0.01%
11,299
-9,002
-44% -$114K
GDRX icon
741
GoodRx Holdings
GDRX
$1.16B
$139K ﹤0.01%
+48,289
New +$123K
DCH
742
Dauch Corp
DCH
$1.54B
$133K ﹤0.01%
+24,584
New +$149K
CLNE icon
743
Clean Energy Fuels
CLNE
$359M
$128K ﹤0.01%
62,279
-35,235
-36% -$74.9K
VLRS
744
Controladora Vuela Compania de Aviacion
VLRS
$749M
$124K ﹤0.01%
+13,268
New +$102K
GRAB icon
745
Grab
GRAB
$12.5B
$120K ﹤0.01%
31,828
+16,669
+110% +$60.7K
ENVX icon
746
Enovix
ENVX
$680M
$118K ﹤0.01%
+19,359
New +$128K
RCKT icon
747
Rocket Pharmaceuticals
RCKT
$368M
$111K ﹤0.01%
32,458
-17,336
-35% -$57.6K
RNW icon
748
ReNew
RNW
$2.49B
$104K ﹤0.01%
16,682
-36,922
-69% -$208K
ABUS icon
749
Arbutus Biopharma
ABUS
$1.01B
$94.8K ﹤0.01%
+19,741
New +$86.7K
IVVD icon
750
Invivyd
IVVD
$232M
$84.8K ﹤0.01%
+97,214
New +$122K
28 29
30
31 32

Similar funds

GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $5.5B AUM 26.66% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
NC
Nicholas Company Milwaukee, Wisconsin $5.47B AUM 16.96% 1-Year Est. Return
EI
EFG International Zurich $5.46B AUM
MC
Maplelane Capital New York $5.51B AUM 67.92% 1-Year Est. Return
AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return

Voleon Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Voleon Capital Management held 957 positions worth $5.49B, up 18% from $4.64B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Voleon Capital Management's Q2 2026 filing shows 177 new, 251 increased, 333 reduced and 196 closed positions. Its largest new stake was AstraZeneca: 125,385 shares worth $23.8M. The largest sale was Astera Labs, an estimated $29.3M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.

  • Voleon Capital Management's largest Q2 2026 buy was AstraZeneca: 125,385 shares worth $23.8M.
  • Voleon Capital Management added most to Microsoft in Q2 2026, an estimated $41.7M increase.
  • Voleon Capital Management's biggest Q2 2026 reduction was Astera Labs, cutting an estimated $29.3M.
  • Voleon Capital Management fully exited Ascendis Pharma A/S in Q2 2026, selling an estimated $15.5M.
  • Voleon Capital Management's ten largest holdings make up 29% of its $5.49B portfolio in Q2 2026.
  • Voleon Capital Management opened 177 new positions and closed 196 in Q2 2026.
  • Voleon Capital Management's portfolio value rose 18% quarter-over-quarter to $5.49B.

Based on Voleon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.